Geron reported $123.6M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Amgen USD 6.22B 34M Jun/2026
Bio Techne USD 201.18M 4.27M Mar/2026
Cytokinetics USD 380K 226K Jun/2026
Exelixis USD 26.6M 4.92M Mar/2026
Genmab DKK 13M 1000K Jun/2025
Geron USD 123.6M 9.68M Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Incyte USD 112.54M 3.08M Jun/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Novavax USD 10.01M 1.45M Jun/2026